VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K952. A total of 6 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $15,828,000 | +45.0% | 761,700 | 0.0% | 0.10% | +11.7% |
| Q3 2017 | $10,915,000 | -30.3% | 761,700 | -15.8% | 0.09% | -34.7% |
| Q2 2017 | $15,655,000 | +50.2% | 904,900 | -4.2% | 0.14% | +12.5% |
| Q1 2017 | $10,422,000 | -81.0% | 944,900 | -74.9% | 0.13% | -81.7% |
| Q4 2016 | $54,745,000 | -40.9% | 3,770,300 | 0.0% | 0.70% | -18.5% |
| Q3 2016 | $92,561,000 | +21.9% | 3,770,300 | 0.0% | 0.86% | -15.3% |
| Q2 2016 | $75,934,000 | +19.3% | 3,770,300 | +55.8% | 1.01% | +117.1% |
| Q1 2016 | $63,641,000 | +172.2% | 2,419,800 | +952.1% | 0.47% | +190.1% |
| Q4 2015 | $23,380,000 | -19.0% | 230,000 | +4.5% | 0.16% | -42.1% |
| Q3 2014 | $28,864,000 | -28.5% | 220,000 | -31.2% | 0.28% | -35.0% |
| Q2 2014 | $40,358,000 | – | 320,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|